We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
70 hedge funds and large institutions have $404M invested in Zevra Therapeutics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
866% more capital invested
Capital invested by funds: $41.8M → $404M (+$362M)
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
1% more funds holding
Funds holding: 69 → 70 (+1)
1% less call options, than puts
Call options by funds: $4.05M | Put options by funds: $4.11M
2.25% less ownership
Funds ownership: 19.41% → 17.16% (-2.2%)
23% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 22
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
70
Holders Change
+1
Holders Change %
+1.45%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
10
Increased
17
Reduced
22
Closed
8
Calls
$4.05M
Puts
$4.11M
Net Calls
-$58K
Net Calls Change
+$2.92M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$553K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$386K |
| 3 |
Citigroup
New York
|
+$344K |
| 4 |
Jane Street
New York
|
+$162K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$128K |
Top Sellers
| 1 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$2.13M |
| 2 |
BlackRock
New York
|
-$1.24M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$907K |
| 4 |
E
Ergoteles
New York
|
-$535K |
| 5 |
Millennium Management
New York
|
-$385K |
